Results 161 to 170 of about 96,976 (289)

Laporan Kasus: Otitis Media Tuberkulosis dengan Kolesteatoma pada Anak

open access: yesJurnal Ilmiah Kedokteran Wijaya Kusuma, 2019
Otitis media tuberkulosis adalah peradangan  kronik mukosa telinga tengah yang disebabkan oleh mycobacterium tuberculosis. Gejala klasik otitis media tuberkulosis adalah  perforasi multipel membrane timpani, otore tanpa nyeri dan jaringan granulasi yang ...
Riyan Charlie Milyantono   +1 more
doaj  

Filling the gaps to empower regional centres to manage myelodysplastic syndrome and acute myeloid leukaemia leading to wider cancer healthcare delivery and access to clinical trials

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background The management of patients with haematological malignancies in rural and regional Australia is different to that in metropolitan centres due to many factors. Lower‐intensity and easier‐to‐access treatments that are now available for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) have improved the deliverability of ...
Michael Ashby   +4 more
wiley   +1 more source

Advancing adolescent bedtime by motivational interviewing and text message: a randomized controlled trial

open access: yesJournal of Child Psychology and Psychiatry, EarlyView.
Background Sleep deprivation is a prevalent problem among adolescents which is closely related to various adverse outcomes. The lack of efficacy of current sleep education programs among adolescents argues for the need to refine the content and format of the intervention.
Ngan Yin Chan   +10 more
wiley   +1 more source

Acute Otitis Media [PDF]

open access: green, 1936
Alyson Campbell
openalex   +1 more source

Efficacy and safety of tozorakimab in moderate‐to‐severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER‐2)

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In FRONTIER‐2 (NCT04212169), a Phase 2a, randomized, placebo‐controlled study of 148 adults with moderate‐to‐severe atopic dermatitis, no statistically significant differences between tozorakimab and placebo were observed in the percentage change in EASI score from baseline to Week 16.
J. I. Silverberg   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy